The 1.4 million-ft² facility employs 2,500 people and is the largest manufacturer of intravenous and peritoneal dialysis ...

Baxter expects to reach 100% allocation across several IV product codes by the end of 2023. The company plans to increase production capacity through phased updates in late November, mid-December and ...

The company, which is a key producer for American healthcare providers, was hit by the hurricane when it tore through western ...

Baxter International Inc.’s Marion plant is now producing a limited amount of IV solutions, the manufacturer said Thursday.

Most of Nashville's hospitals have a healthy supply of fluids, but they are continuing to assess sometimes daily and search ...

On Oct. 9, the U.S. Food & Drug Administration authorized Baxter to import intravenous solution and dialysis products from sites in Canada, China, Ireland and the U.K. Airlifting in supplies is ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Baxter International (BAX) stock slips as the company with its Q3 2024 results lowers guidance to reflect a $200M revenue hit ...

Baxter expects to restart a second IV solutions manufacturing line within the next week, the company announced Nov. 7. Along ...

(Bloomberg) -- Baxter International Inc. will begin accepting more new home dialysis patients after ... Baxter said. The IV ...

The global dialysis equipment market is on a strong growth trajectory, with projected sales expected to increase from USD ...